- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 562984, 12 pages
Aminopeptidase N (CD13) Is Involved in Phagocytic Processes in Human Dendritic Cells and Macrophages
Departamento de Inmunología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Apartado Postal 70228, Ciudad Universitaria, 04510 México, DF, Mexico
Received 27 April 2013; Revised 4 July 2013; Accepted 7 July 2013
Academic Editor: Guillermina Girardi
Copyright © 2013 Mónica I. Villaseñor-Cardoso et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- D. Riemann, A. Kehlen, and J. Langner, “CD13-not just a marker in leukemia typing,” Immunology Today, vol. 20, no. 2, pp. 83–88, 1999.
- Y. Zhuang, W. Mwangi, W. C. Brown, W. C. Davis, J. C. Hope, and G. H. Palmer, “Characterization of a phenotypically unique population of CD13+ dendritic cells resident in the spleen,” Clinical and Vaccine Immunology, vol. 13, no. 9, pp. 1064–1069, 2006.
- M. Ghosh, B. McAuliffe, J. Subramani, S. Basu, and L. H. Shapiro, “CD13 regulates dendritic cell cross-presentation and T cell responses by inhibiting receptor-mediated antigen uptake,” Journal of Immunology, vol. 188, no. 11, pp. 5489–5499, 2012.
- D. Fontijn, M. C. A. Duyndam, M. P. A. Van Berkel et al., “CD13/Aminopeptidase N overexpression by basic fibroblast growth factor mediates enhanced invasiveness of 1F6 human melanoma cells,” British Journal of Cancer, vol. 94, no. 11, pp. 1627–1636, 2006.
- R. Pasqualini, E. Koivunen, R. Kain et al., “Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis,” Cancer Research, vol. 60, no. 3, pp. 722–727, 2000.
- H. Fujii, M. Nakajima, I. Saiki, J. Yoneda, I. Azuma, and T. Tsuruo, “Human melanoma invasion and metastasis enhancement by high expression of aminopeptidase N/CD13,” Clinical and Experimental Metastasis, vol. 13, no. 5, pp. 337–344, 1995.
- P. Mina-Osorio, “The moonlighting enzyme CD13: old and new functions to target,” Trends in Molecular Medicine, vol. 14, no. 8, pp. 361–371, 2008.
- I. Jutras and M. Desjardins, “Phagocytosis: at the crossroads of innate and adaptive immunity,” Annual Review of Cell and Developmental Biology, vol. 21, pp. 511–527, 2005.
- E. Groves, A. E. Dart, V. Covarelli, and E. Caron, “Molecular mechanisms of phagocytic uptake in mammalian cells,” Cellular and Molecular Life Sciences, vol. 65, no. 13, pp. 1957–1976, 2008.
- L. M. Stuart and R. A. B. Ezekowitz, “Phagocytosis: elegant complexity,” Immunity, vol. 22, no. 5, pp. 539–550, 2005.
- N. Tokuda and R. B. Levy, “1,25-Dihydroxyvitamin D3 stimulates phagocytosis but suppresses HLA-DR and CD13 antigen expression in human mononuclear phagocytes,” Proceedings of the Society for Experimental Biology and Medicine, vol. 211, no. 3, pp. 244–250, 1996.
- P. Mina-Osorio and E. Ortega, “Aminopeptidase N (CD13) functionally interacts with FcγRs in human monocytes,” Journal of Leukocyte Biology, vol. 77, no. 6, pp. 1008–1017, 2005.
- J. Gabrilovac, B. Čupić, E. Živković, L. Horvat, and D. Majhen, “Expression, regulation and functional activities of aminopeptidase N (EC 126.96.36.199; APN; CD13) on murine macrophage J774 cell line,” Immunobiology, vol. 216, no. 1-2, pp. 132–144, 2011.
- B. Winnicka, C. O'Conor, W. Schacke et al., “CD13 is dispensable for normal hematopoiesis and myeloid cell functions in the mouse,” Journal of Leukocyte Biology, vol. 88, no. 2, pp. 347–359, 2010.
- C. F. Bassoe, “Assessment of phagocyte functions by flow cytometry,” in Current Protocols in Cytometry, chapter 9, unit 9, p. 19, 2002.
- F. Grassi, C. Dezutter-Dambuyant, D. McIlroy et al., “Monocyte-derived dendritic cells have a phenotype comparable to that of dermal dendritic cells and display ultrastructural granules distinct from Birbeck granules,” Journal of Leukocyte Biology, vol. 64, no. 4, pp. 484–493, 1998.
- K. M. Dennehy, G. Ferwerda, I. Faro-Trindade et al., “Syk kinase is required for collaborative cytokine production induced through Dectin-1 and Toll-like receptors,” European Journal of Immunology, vol. 38, no. 2, pp. 500–506, 2008.
- R. Schwandner, R. Dziarski, H. Wesche, M. Rothe, and C. J. Kirschning, “Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2,” Journal of Biological Chemistry, vol. 274, no. 25, pp. 17406–17409, 1999.
- A. Yoshimura, E. Lien, R. R. Ingalls, E. Tuomanen, R. Dziarski, and D. Golenbock, “Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2,” Journal of Immunology, vol. 163, no. 1, pp. 1–5, 1999.
- M. López-Bravo and C. Ardavín, “In Vivo induction of immune responses to pathogens by conventional dendritic cells,” Immunity, vol. 29, no. 3, pp. 343–351, 2008.
- A. A. Amoscato, D. A. Prenovitz, and M. T. Lotze, “Rapid extracellular degradation of synthetic class I peptides by human dendritic cells,” Journal of Immunology, vol. 161, no. 8, pp. 4023–4032, 1998.
- S. L. Larsen, L. Ø. Pedersen, S. Buus, and A. Stryhn, “T cell responses affected by aminopeptidase N (CD13)-mediated trimming of major histocompatibility complex class II-bound peptides,” Journal of Experimental Medicine, vol. 184, no. 1, pp. 183–189, 1996.
- X. Dong, B. An, L. S. Kierstead, W. J. Storkus, A. A. Amoscato, and R. D. Salter, “Modification of the amino terminus of a class II epitope confers resistance to degradation by CD13 on dendritic cells and enhances presentation to T cells,” Journal of Immunology, vol. 164, no. 1, pp. 129–135, 2000.
- V. E. Woodhead, T. J. Stonehouse, M. H. Binks et al., “Novel molecular mechanisms of dendritic cell-induced T cell activation,” International Immunology, vol. 12, no. 7, pp. 1051–1061, 2000.
- V. H. J. van der Velden, P. J. M. Leenen, and H. A. Drexhage, “CD13/aminopeptidase N involvement in dendritic cell maturation,” Leukemia, vol. 15, no. 1, pp. 190–191, 2001.
- G. D. Brown and S. Gordon, “A new receptor for β-glucans,” Nature, vol. 413, no. 6851, pp. 36–37, 2001.
- S. Józefowski, Z. Yang, J. Marcinkiewicz, and L. Kobzik, “Scavenger receptors and β-glucan receptors participate in the recognition of yeasts by murine macrophages,” Inflammation Research, vol. 61, no. 2, pp. 113–126, 2012.
- T. E. Mollnes, O. Brekke, M. Fung et al., “Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation,” Blood, vol. 100, no. 5, pp. 1869–1877, 2002.
- O. Brekke, D. Christiansen, H. Fure, M. Fung, and T. E. Mollnes, “The role of complement C3 opsonization, C5a receptor, and CD14 in E. coli-induced up-regulation of granulocyte and monocyte CD11b/CD18 (CR3), phagocytosis, and oxidative burst in human whole blood,” Journal of Leukocyte Biology, vol. 81, no. 6, pp. 1404–1413, 2007.
- P. Mina-Osorio, I. Soto-Cruz, and E. Ortega, “A role for galectin-3 in CD13-mediated homotypic aggregation of monocytes,” Biochemical and Biophysical Research Communications, vol. 353, no. 3, pp. 605–610, 2007.
- E. Yang, J. S. Shim, H. Woo, K. Kim, and H. J. Kwon, “Aminopeptidase N/CD13 induces angiogenesis through interaction with a pro-angiogenic protein, galectin-3,” Biochemical and Biophysical Research Communications, vol. 363, no. 2, pp. 336–341, 2007.
- G. R. Vasta, “Roles of galectins in infection,” Nature Reviews Microbiology, vol. 7, no. 6, pp. 424–438, 2009.
- A. N. Santos, J. Langner, M. Herrmann, and D. Riemann, “Aminopeptidase N/CD13 is directly linked to signal transduction pathways in monocytes,” Cellular Immunology, vol. 201, no. 1, pp. 22–32, 2000.
- P. Mina-Osorio, L. H. Shapiro, and E. Ortega, “CD13 in cell adhesion: aminopeptidase N (CD13) mediates homotypic aggregation of monocytic cells,” Journal of Leukocyte Biology, vol. 79, no. 4, pp. 719–730, 2006.
- A. H. Wong, D. Zhou, and J. M. Rini, “The X-ray crystal structure of human aminopeptidase N reveals a novel dimer and the basis for peptide processing,” Journal of Biological Chemistry, vol. 287, pp. 36804–36813, 2012.
- E. Van Hamme, L. Desmarets, H. L. Dewerchin, and H. J. Nauwynck, “Intriguing interplay between feline infectious peritonitis virus and its receptors during entry in primary feline monocytes,” Virus Research, vol. 160, no. 1-2, pp. 32–39, 2011.
- W. Kramer, F. Girbig, D. Corsiero et al., “Aminopeptidase N (CD13) is a molecular target of the cholesterol absorption inhibitor Ezetimibe in the enterocyte brush border membrane,” Journal of Biological Chemistry, vol. 280, no. 2, pp. 1306–1320, 2005.
- D. Reinhold, A. Biton, A. Goihl et al., “Dual inhibition of dipeptidyl peptidase IV and aminopeptidase N suppresses inflammatory immune responses,” Annals of the New York Academy of Sciences, vol. 1110, pp. 402–409, 2007.
- B. Lkhagvaa, K. Tani, K. Sato, Y. Toyoda, C. Suzuka, and S. Sone, “Bestatin, an inhibitor for aminopeptidases, modulates the production of cytokines and chemokines by activated monocytes and macrophages,” Cytokine, vol. 44, no. 3, pp. 386–391, 2008.
- U. Lendeckel, M. Arndt, A. Bukowska et al., “Synergistic action of DPIV and APN in the regulation of T cell function,” Advances in Experimental Medicine and Biology, vol. 524, pp. 123–131, 2003.